The mainstay of treatment in patients with epilepsy is antiepileptic drugs (AEDs). Currently, there are a significant number of AEDs in Mexico. For the pharmacological management of the patient with epilepsy, it is important to know the pharmacoki-netics, dosage, mechanism of action, and formulations of the AED. 70-80% of patients with either focal or generalized seizures are completely seizure free on AED monotherapy. When, despite the use of AED in monotherapy, seizure freedom is not achieved, a second AED should be used; AEDs with different mechanisms of action are empirically combined for this purpose. If a patient persists in having seizures with the use of an adequate AED, at appropriate doses and with therapeutic adherence, a correct diagnosis of the seizure type and a differential diagnosis should be reconsidered, using a new clinical evaluation and auxiliary diagnostic tests.
CITATION STYLE
Rivera-Castaño, L., Sentíes-Madrid, H., Berumen-Jaik, J., & Martínez-Juárez, I. E. (2021). Clinical guideline: antiepileptic drugs of choice for focal and generalized seizures in adult patients with epilepsy. Revista Mexicana de Neurociencia, 20(2). https://doi.org/10.24875/rmn.m19000027
Mendeley helps you to discover research relevant for your work.